EUVIMEDEUVIMED entdecken
Open Access

Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges

Fasil Tekola-Ayele, Charles N Rotimi

Public Health Genomics · 2015 · 18 (4) · 242-247

DOI: 10.1159/000433518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Genomics, online erschienen am 26.06.2015. Verfasst von Fasil Tekola-Ayele und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Md., USA. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIMHD NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Translation of genomic discoveries into patient care is slowly becoming a reality in developed economies around the world. In contrast, low- and middle-income countries (LMIC) have participated minimally in genomic research for several reasons including the lack of coherent national policies, the limited number of well-trained genomic scientists, poor research infrastructure, and local economic and cultural challenges. Recent initiatives such as the Human Heredity and Health in Africa (H3Africa), the Qatar Genome Project, and the Mexico National Institute of Genomic Medicine (INMEGEN) that aim to address these problems through capacity building and empowerment of local researchers have sparked a paradigm shift. In this short communication, we describe experiences of small-scale medical genetics and translational genomic research programs in LMIC. The lessons drawn from these programs drive home the importance of addressing resource, policy, and sociocultural dynamics to realize the promise of precision medicine driven by genomic science globally. By echoing lessons from a bench-to-community translational genomic research, we advocate that large-scale genomic research projects can be successfully linked with health care programs. To harness the benefits of genomics-led health care, LMIC governments should begin to develop national genomics policies that will address human and technology capacity development within the context of their national economic and sociocultural uniqueness. These policies should encourage international collaboration and promote the link between the public health program and genomics researchers. Finally, we highlight the potential catalytic roles of the global community to foster translational genomics in LMIC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capacity BuildingCommunicable DiseasesDelivery of Health CareDeveloping CountriesFamily HealthGenetics, MedicalGenome, HumanGenomicsHealth PolicyHumansInternational CooperationPharmacogeneticsPublic HealthTranslational Research, Biomedical

Autor:innen und Institutionen

  • Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Md., USA.

Förderung

  • Wellcome Trust
  • NIMHD NIH HHS
  • Intramural NIH HHS
  • PHS HHS

Zitieren

APA

Tekola-Ayele, F., & Rotimi, C. N. (2015). Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges. Public Health Genomics, 18(4), 242-247. https://doi.org/10.1159/000433518

Vancouver

Tekola-Ayele F, Rotimi CN. Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges. Public Health Genomics. 2015;18(4):242-247. doi:10.1159/000433518

BibTeX
@article{TekolaAyele2015,
  author = {Tekola-Ayele, Fasil and Rotimi, Charles N},
  title = {Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges},
  journal = {Public Health Genomics},
  year = {2015},
  volume = {18},
  number = {4},
  pages = {242--247},
  doi = {10.1159/000433518}
}
Kostenlos starten →